secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2026-08-10T21:00:22+00:00
Accession:  0001640334-26-001302
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria Bioscience receives Nasdaq delisting notice but expects compliance via reverse split
--------------------------------------------------------------------------------

- Received Nasdaq delisting notice Aug 4, 2026 for failing to regain $1 minimum bid price within 180-day period.
- Completed reverse stock split Aug 3, 2026 (announced Jul 30); shares now trading above $1 under CUSIP 52886N604.
- Filed hearing request and paid fee to stay delisting; expects to regain compliance before hearing date.
- Company expects shares to continue trading on Nasdaq without interruption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033426001302/0001640334-26-001302-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033426001302/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-001302

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer